A prototype liver-specific contrast medium for CT: Preclinical evaluation of gadoxetic acid disodium, or Gd-EOB-DTPA

Radiology

Volumn 202, Issue 2, 1997, Pages 407-412

  Schmitz, Stephan A ^a   Wagner, Susanne ^a   Schuhmann Giampieri, Gabriele ^b   Krause, Werner ^b   Wolf, Karl Jürgen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Institute of Diagnostic Research   (Germany)

Author keywords

Computed tomography (CT), contrast enhancement; Computed tomography (CT), contrast media; Contrast media, experimental studies; Gadolinium; Iodine and iodine compounds; Liver neoplasms, CT

Indexed keywords

GADOLINIUM PENTETATE; GADOLINIUM PENTETATE DERIVATIVE; GADOXETIC ACID; IOHEXOL; IOPAMIDOL; IOPROMIDE; MANGAFODIPIR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOG; HEPATOGRAPHY; IMAGE QUALITY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0031015917     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.202.2.9015066     Document Type: Article

References (20)

1. Ferrucci JT. Liver tumor imaging: issues of the 1990s. In: Ferrucci JT, Stark DD, eds. Liver imaging: current trends and new techniques. Boston, Mass: Andover Medical, 1990; 1-18.
2. Freeny PC. Hepatic CT: techniques, applications, and results. In: Ferrucci JT, Stark DD, eds. Liver imaging: current trends and new techniques. Boston, Mass: Andover Medical, 1990; 28-38.
3. Miller DL, Simmons JT, Chang R, et al. Hepatic metastases detection: comparison of three CT contrast enhancement methods. Radiology 1987; 165:785-790.
4. Hamm B, Vogl TJ, Branding G, et al. Focal liver lesions: MR imaging with Mn-DPDP -initial clinical results in 40 patients. Radiology 1992; 182:167-174.
5. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992; 183:59-64.
6. Mühler A, Clément O, Vexier V, Berthezéne Y, Rosenau W, Brasch RC. Gadolinium-ethoxybenzyl-DTPA hepatobiliary enhancement: comparison of spin echo and STIR imaging for detection of experimental liver metastases. Radiology 1992; 184:207-213.
7. Foley WD. Dynamic hepatic CT. Radiology 1989; 170:617-622.
8. Sugarbaker PH, Vermess M, Doppman JL, Miller DL, Simon R. Improved detection of focal lesions with computerized tomographic examination of the liver using ethiodized oil emulsion (EOE-13) liver contrast. Cancer 1984; 54:1489-1495.
9. Bernardino ME, Erwin BC, Steinberg HV, Baumgartner BR, Torres WE, Gedbaudas-McClees K. Delayed hepatic CT scanning: increased confidence and improved detection of hepatic metastases. Radiology 1986; 159:71-74
10. Perkerson RB, Erwin BC, Baumgartner BR, et al. CT densities in delayed iodine hepatic scanning. Radiology 1985; 155:445-446.
11. Miller DL, Vermess M, Doppman JL, et al. CT of the liver and spleen with EOE-13: review of 225 examinations. AJR 1985; 155: 445-446.
12. Miller DL, Simmons JT, Chang R, et al. Hepatic metastasis detection: comparison of three CT contrast enhancement methods. Radiology 1987; 165:785-790.
13. Nelson R, Chezmar JL, Sugarbaker PH, Bernardino ME. Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation. Radiology 1989; 172:27-34.
14. Zwicker C, Langer M, Urich V, Felix R. Contrast opacification for CT from iodine, gadolinium, and ytterbium: in vitro and animal experiments. ROFO 1993; 158:255-259.
15. Schmitz SA, Wagner S, Schuhmann-Giampieri G, Wolf KJ. Evaluation of gadobutrol in a rabbit model as a new lanthanide contrast agent for computed tomography. Invest Radiol 1995; 11:644-649.
16. Engelbrecht V, Koch JA, Rassek M, Mödder U. Gadolinium-DTPA and gadodiamide as an alternative contrast medium for CT. ROFO 1996; 165:24-28.
17. Weast RC. Handbook of chemistry and physics: a ready-reference book of chemical and physical data. Cleveland, Ohio: Chemical Rubber, 1981-1982.
18. Wedeking P, Sotak CH, Telser J, Kumar K, Chang CA, Tweedle MF. Quantitative dependence of MR signal intensity on tissue concentration of Gd(HP-DO3A) in the nephrectomized rat. Magn Reson Imaging 1992; 10:97-108.
19. 153gadolinium-EOB-DTPA scintigraphy in rats. Invest Radiol 1996; 31:154-160.
20. Hamm B, Staks, T, Mühler A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995; 195:785-792.